Drawing for VAVELTA

USPTO serial 77228265

VAVELTA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
KAJUBI, ELIZABETH N
Law office
TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with VAVELTA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Corey K. Cho

COREY K. CHO SALIWANCHIK, LLOYD & SALIWANCHIKPO BOX 142950GAINESVILLE, FL 32614-2950UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Therapeutic and biological products and preparations in the nature of biological skin repairing preparations taken by injection to induce regenerating and rejuvenating of the aging and/or damaged skin, namely, injectable suspensions of cells administered directly into the skin in order to regenerate and rejuvenate skin tissue that is damaged by scarring, wounds, disease, and to reduce and alleviate wrinkles and other effects of aging on the skin, all for aesthetic use; therapeutic biological products and preparations for aesthetic use, namely, biological skin repairing preparations taken by injection to induce regenerating and rejuvenating of the aging and/or damaged skin, namely, injectable suspensions of cells administered directly into the skin in order to regenerate and rejuvenate skin tissue that is damaged by scarring, wounds, disease, and to reduce and alleviate wrinkles and other effects of aging on the skin; biological substances for aesthetic use, namely, biological skin repairing preparations taken by injection to induce regenerating and rejuvenating of the aging and/or damaged skin, namely, injectable suspensions of cells administered directly into the skin in order to regenerate and rejuvenate skin tissue that is damaged by scarring, wounds, disease, and to reduce and alleviate wrinkles and other effects of aging on the skin; skin regenerating preparations for aesthetic useACTIVE—
005Therapeutic and biological products and preparations in the nature of biological preparations for medical use; therapeutic biological products, namely, biological preparations for medical use; biological substances, namely, biological preparations for medical use; therapeutic agents for the treatment of skin imperfections and skin contractures, and for dermal rejuvenation; cell-based therapeutic agents, namely, cellular implants for medical use; biological tissue, namely, bone tissue, skin tissue or other connective tissue, intended for subsequent implantation or application; tissue regeneration materials, namely, human allograft or autograft tissue; surgical implants and applications comprising living tissue; nutritive agents in the nature of cell culture media for processing living cells; facial and dermal rejuvenation products for medical use, namely, injectable suspensions of cells administered directly into the skin in order to regenerate and rejuvenate skin tissue that is damaged by scarring, wounds, disease, or other skin damage, and to reduce and alleviate wrinkles and other effects of aging on the skin; skin regenerating preparations for medical use; cell-based therapeutic agents, namely, cellular implants for medical and aesthetic useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Dec 22, 2009MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 22, 2009ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 9, 2009GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 9, 2009GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 9, 2009CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 18, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 18, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 17, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 17, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 17, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 17, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 26, 2008ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Aug 18, 2008PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Aug 6, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 31, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 30, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 30, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 30, 2008ALIEASSIGNED TO LIE—
Jul 29, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 20, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 19, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 18, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 18, 2008ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Dec 18, 2007GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 18, 2007GNSLLETTER OF SUSPENSION E-MAILED—
Dec 18, 2007CNSLSUSPENSION LETTER WRITTEN—
Dec 6, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 5, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 5, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 26, 2007GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 26, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 26, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 16, 2007DOCKASSIGNED TO EXAMINER—
Jul 17, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance